2 active not recruiting, 1 recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 2 |
| Phase 2 | 1 | Recruiting 1 |
Follow Stage III Penile Cancer AJCC v8: new trials by email Literature Review of Stage III Penile Cancer AJCC v8 trials Research Report on Stage III Penile Cancer AJCC v8
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis Enfortumab Vedotin, Computed Tomography, Magnetic Resonance Imaging - Metastatic Penile Squamous Cell Carcinoma, Stage III Penile Cancer AJCC v8 | Phase 2 | Recruiting | Mayo Clinic | 28 | 2023-12-21 | 2026-06-08 |
| Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer Cisplatin, Elimusertib, Gemcitabine Hydrochloride - Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 74 | 2021-08-25 | 2026-07-31 |
| Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors Biopsy Procedure, Biospecimen Collection, Cabozantinib S-malate - Bladder Small Cell Neuroendocrine Carcinoma, Bladder Squamous Cell Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 152 | 2015-07-22 | 2026-10-15 |
Penile Neoplasms (3) · Carcinoma, Renal Cell (1) · Lung Neoplasms (1) · Mesothelioma, Malignant (1) · Ovarian Neoplasms (1) · Triple Negative Breast Neoplasms (1) · Ureteral Neoplasms (1) · Urethral Neoplasms (1) · Urinary Bladder Neoplasms (1) · Urogenital Neoplasms (1) · Uterine Cervical Neoplasms (1)
Genital Diseases (3) · Genital Diseases, Male (3) · Genital Neoplasms, Male (3) · Male Urogenital Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Penile Diseases (3) · Urogenital Diseases (3) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Urogenital Neoplasms (2) · Adenocarcinoma (1) · Adenoma (1)
Magnetic Resonance Spectroscopy (2) · 1,2-diaminocyclohexaneplatinum II citrate (1) · BAY 1895344 (1) · Biopsy (1) · CTLA-4 Antigen (1) · Cisplatin (1) · Gemcitabine (1) · Ipilimumab (1) · Nivolumab (1) · Platinum (1) · Specimen Handling (1) · cabozantinib (1) · enfortumab vedotin (1)
National Cancer Institute (NCI) (2) · Mayo Clinic (1)
United States (3) · Canada (1)
Andrea B Apolo (1) · Lance C. Pagliaro, M.D. (1) · Mamta Parikh (1)
PMID 32915679, PMID 35031545, PMID 38954785
UM1CA186717 (2), UM1CA186712 (1), UM1CA186716 (1), ZIABC011078 (1)